CHARACTERIZATION STUDIES ON A TETRAHYDROCURCUMIN-ZINC COMPLEX
DOI:
https://doi.org/10.22159/ijpps.2022v14i11.44720Keywords:
Tetrahydrocurcumin, Zinc, Complex formation, UV-Vis absorption spectroscopy, Fourier transform infrared spectroscopy, Mass spectrometry, Nuclear magnetic resonance spectroscopyAbstract
Objective: Preparation and characterization studies on tetrahydrocurcumin complexed with zinc, with particular reference to the location of zinc in the complex.
Methods: Structural characteristics of tetrahydrocurcumin and its complex with zinc were compared using elemental analysis, mass spectrometry (MS), proton, and carbon-13 nuclear magnetic resonance spectroscopy (NMR), ultraviolet-visible (UV) absorption spectroscopy, and Fourier transform infrared (FTIR) spectroscopy.
Results: MS data indicates a Zn molecule holds two THCur components together. NMR data provide evidence that the zinc ion is associated with the 1,3-diketone part of the linker region of the associated THCur. FTIR data is consistent with zinc interaction with the enol tautomer of the 1,3-diketone at the center of the linker region of THCur. UV data indicate that a zinc-dependent shift in absorbance maximum is consistent with changes in the structure of THCur resulting from complexation with zinc. Together, this data indicates the complexation of zinc with tetrahydrocurcumin is consistent with zinc linking two molecules of tetrahydrocurcumin together by binding to the enol forms of the 1,3-diketone moieties located in the linker regions between the aromatic rings.
Conclusion: The spectral properties of the tetrahydrocurcumin-zinc complex are consistent with a structure in which zinc is encased in two tetrahydrocurcumin moieties. Additional studies are needed to determine if this structure results in altered bioavailability, antioxidant activity and other properties important for pharmaceutical development.
Downloads
References
Chand N. Standardized turmeric and curcumin. In: Gupta RC, Srivastava A, Lall R, editors. Nutraceuticals in veterinary medicine. 1st ed. New York: Springer Publishing; 2019. p. 3-24.
Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60(5):1620-37. doi: 10.1021/acs.jmedchem.6b00975, PMID 28074653.
Sareen R, Jain N, Dhar KL. Curcumin–Zn(II) complex for enhanced solubility and stability: an approach for improved delivery and pharmacodynamic effects. Pharm Dev Technol. 2016;21(5):630-5. doi: 10.3109/10837450.2015.1041042, PMID 25923136.
Yan FS, Sun JL, Xie WH, Shen L, Ji HF. Neuroprotective Effects and mechanisms of curcumin-Cu(II) and -Zn(II) complexes systems and their pharmacological implications. Nutrients. 2017;10(1). doi: 10.3390/nu10010028. PMID 29283372.
Hieu TQ, Thao DTT. Enhancing the solubility of curcumin metal complexes and investigating some of their biological activities. J Chem. 2019. doi: 10.1155/2019/8082195.
Shakeri A, Panahi Y, Johnston TP, Sahebkar A. Biological properties of metal complexes of curcumin. BioFactors. 2019;45(3):304-17. doi: 10.1002/biof.1504, PMID 31018024.
Aggarwal BB, Deb L, Prasad S. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules. 2014;20(1):185-205. doi: 10.3390/molecules20010185, PMID 25547723.
Yáñez JA, Wang SW, Knemeyer IW, Wirth MA, Alton KB. Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev. 2011;63(10-11):923-42. doi: 10.1016/j.addr.2011.05.019, PMID 21689702.
Sangartit W, Kukongviriyapan U, Donpunha W, Pakdeechote P, Kukongviriyapan V, Surawattanawan P. Tetrahydrocurcumin protects against cadmium-induced hypertension, raised arterial stiffness and vascular remodeling in mice. PLOS ONE. 2014;9(12):e114908. doi: 10.1371/journal.pone.0114908. PMID 25502771.
Colombo A, Fontani M, Dragonetti C, Roberto D, Williams JAG, Scotto di Perrotolo R. A highly luminescent tetrahydrocurcumin IrIII complex with remarkable photoactivated anticancer activity. Chemistry. 2019;25(33):7948-52. doi: 10.1002/chem.201901527. PMID 30985041.
Banerjee R. Inhibitory effect of curcumin-Cu(II) and curcumin-Zn(II) complexes on amyloid-beta peptide fibrillation. Bioinorg Chem Appl. 2014;2014:325873. doi: 10.1155/2014/325873, PMID 25147492.
Haase H, Rink L. The immune system and the impact of zinc during aging. Immun Ageing. 2009;6:9. doi: 10.1186/1742-4933-6-9, PMID 19523191.
Hojyo S, Fukada T. Roles of zinc signaling in the immune system. J Immunol Res. 2016;2016:6762343. doi: 10.1155/2016/6762343, PMID 27872866.
Prasad AS. Impact of the discovery of human zinc deficiency on health. J Am Coll Nutr. 2009;28(3):257-65. doi: 10.1080/07315724.2009.10719780, PMID 20150599.
United States Environmental Protection Agency. Washington, DC, USA. Method 6010D. 4th revision. 2014;SW-846.
Aliyu R, Okoye ZSC, Shier WT. The hepatoprotective cytochrome P-450 enzyme inhibitor isolated from the Nigerian medicinal plant Cochlospermum planchonii is a zinc salt. J Ethnopharmacol. 1995;48(2):89-97. doi: 10.1016/0378-8741(95)01290-t, PMID 8583799.
Peni P, Sasri R, Silalahi IH. Synthesis of metal–curcumin complex compounds (M = Na⁺, Mg²⁺, Cu²⁺). J Kim Sains Apl. 2020;23(3):75-82. doi: 10.14710/jksa.23.3.75-82.
Khalil MI, Al-Zahem AM, Al-Qunaibit MH. Synthesis, characterization, Mössbauer parameters, and antitumor activity of Fe(III) curcumin complex. Bioinorg Chem Appl. 2013;2013:982423. doi: 10.1155/2013/982423, PMID 23606821.
Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu Rev Nutr. 2004;24:151-72. doi: 10.1146/annurev.nutr.24.012003.132402, PMID 15189117.
Rein MJ, Renouf M, Cruz Hernandez C, Actis Goretta L, Thakkar SK, da Silva Pinto M. Bioavailability of bioactive food compounds: a challenging journey to bioefficacy. Br J Clin Pharmacol. 2013;75(3):588-602. doi: 10.1111/j.1365-2125.2012.04425.x, PMID 22897361.
Published
How to Cite
Issue
Section
Copyright (c) 2022 DANIEL J. DUBOURDIEU, SARATH NALLA, JAMIL TALUKDAR, W. THOMAS SHIER
This work is licensed under a Creative Commons Attribution 4.0 International License.
